Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1852 1
1856 2
1971 1
1972 1
1973 2
1974 2
1975 1
1978 1
1980 1
1982 1
1983 2
1986 2
1988 1
1989 7
1990 5
1991 7
1992 7
1993 1
1994 5
1995 5
1996 12
1997 5
1998 6
1999 6
2000 7
2001 11
2002 10
2003 4
2004 6
2005 5
2006 8
2007 11
2008 11
2009 9
2010 5
2011 3
2012 3
2013 9
2014 9
2015 17
2016 9
2017 13
2018 17
2019 15
2020 31
2021 32
2022 27
2023 14
2024 16
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

367 results

Results by year

Filters applied: . Clear all
Page 1
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Sun F, Cheng Y, Wanchai V, Guo W, Mery D, Xu H, Gai D, Siegel E, Bailey C, Ashby C, Al Hadidi S, Schinke C, Thanendrarajan S, Ma Y, Yi Q, Orlowski RZ, Zangari M, van Rhee F, Janz S, Bishop G, Tricot G, Shaughnessy JD Jr, Zhan F. Sun F, et al. Among authors: ashby c. Nat Commun. 2024 Jan 19;15(1):615. doi: 10.1038/s41467-024-44873-4. Nat Commun. 2024. PMID: 38242888 Free PMC article.
Therapeutic strategies to overcome taxane resistance in cancer.
Das T, Anand U, Pandey SK, Ashby CR Jr, Assaraf YG, Chen ZS, Dey A. Das T, et al. Among authors: ashby cr jr. Drug Resist Updat. 2021 Mar;55:100754. doi: 10.1016/j.drup.2021.100754. Epub 2021 Feb 27. Drug Resist Updat. 2021. PMID: 33691261 Review.
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.
Cheng Y, Sun F, Alapat DV, Wanchai V, Mery D, Siegel ER, Xu H, Johnson S, Guo W, Bailey C, Ashby C, Bauer MA, Hadidi SA, Schinke C, Thanendrarajan S, Zangari M, van Rhee F, Tricot G, Shaughnessy JD Jr, Zhan F. Cheng Y, et al. Among authors: ashby c. Blood Cancer J. 2024 Nov 6;14(1):194. doi: 10.1038/s41408-024-01172-x. Blood Cancer J. 2024. PMID: 39505839 Free PMC article.
CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation.
Gai D, Chen JR, Stewart JP, Nookaew I, Habelhah H, Ashby C, Sun F, Cheng Y, Li C, Xu H, Peng B, Garg TK, Schinke C, Thanendrarajan S, Zangari M, Chen F, Barlogie B, van Rhee F, Tricot G, Shaughnessy JD Jr, Zhan F. Gai D, et al. Among authors: ashby c. J Clin Invest. 2022 Sep 15;132(18):e159527. doi: 10.1172/JCI159527. J Clin Invest. 2022. PMID: 35881476 Free PMC article.
High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.
Cheng Y, Sun F, Alapat DV, Wanchai V, Mery D, Guo W, Cao H, Zhu Y, Ashby C, Bauer MA, Nookaew I, Siegel ER, Ying J, Chen JR, Gai D, Peng B, Xu H, Bailey C, Al Hadidi S, Schinke C, Thanendrarajan S, Zangari M, Chesi M, Bergsagel PL, van Rhee F, Janz S, Tricot G, Shaughnessy JD Jr, Zhan F. Cheng Y, et al. Among authors: ashby c. Cell Rep Med. 2023 Oct 17;4(10):101214. doi: 10.1016/j.xcrm.2023.101214. Epub 2023 Oct 3. Cell Rep Med. 2023. PMID: 37794587 Free PMC article.
Doxycycline for ESBL-E Cystitis.
Jodlowski T, Ashby CR, Nath SG. Jodlowski T, et al. Among authors: ashby cr. Clin Infect Dis. 2021 Jul 1;73(1):e274-e275. doi: 10.1093/cid/ciaa1898. Clin Infect Dis. 2021. PMID: 33372961 No abstract available.
Nivolumab and relatlimab for the treatment of melanoma.
Chen XY, Li YD, Xie Y, Cao LQ, Ashby CR Jr, Zhao H, Chen ZS. Chen XY, et al. Among authors: ashby cr jr. Drugs Today (Barc). 2023 Feb;59(2):91-104. doi: 10.1358/dot.2023.59.2.3509756. Drugs Today (Barc). 2023. PMID: 36811409 Review.
367 results